Aveanna Healthcare Holdings Inc [AVAH] stock is trading at $8.36, down -0.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AVAH shares have gain 3.47% over the last week, with a monthly amount glided 12.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] stock has seen the most recent analyst activity on September 18, 2025, when JP Morgan upgraded its rating to a Neutral but kept the price target unchanged to $10 for it. Previously, UBS upgraded its rating to Neutral on August 19, 2025, and kept the price target unchanged to $8. On August 19, 2025, upgrade upgraded it’s rating to Overweight but maintained its price target of $9.50 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $6 on July 21, 2025. Barclays initiated its recommendation with a Equal Weight and recommended $5.50 as its price target on July 02, 2025. JP Morgan downgraded its rating to Underweight for this stock on December 13, 2023. In a note dated November 30, 2023, UBS initiated an Sell rating and provided a target price of $1.50 on this stock.
Aveanna Healthcare Holdings Inc [AVAH] stock has fluctuated between $3.67 and $8.68 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Aveanna Healthcare Holdings Inc [NASDAQ: AVAH] shares were valued at $8.36 at the most recent close of the market. An investor can expect a potential return of 7.66% based on the average AVAH price forecast.
Analyzing the AVAH fundamentals
Aveanna Healthcare Holdings Inc [NASDAQ:AVAH] reported sales of 2.18B for the trailing twelve months, which represents a growth of 16.75%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is -0.19 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -124.35.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.25 points at the first support level, and at 8.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.52, and for the 2nd resistance point, it is at 8.69.
Ratios To Look Out For
For context, Aveanna Healthcare Holdings Inc’s Current Ratio is 1.09. Further, the Quick Ratio stands at 1.09, while the Cash Ratio is 0.24. Considering the valuation of this stock, the price to sales ratio is 0.80 and price to earnings (TTM) ratio is 111.17.
Transactions by insiders
Recent insider trading involved Cunningham Patrick A., Chief Compliance Officer, that happened on Jun 13 ’25 when 18500.0 shares were sold. 10% Owner, J.H. Whitney Equity Partners V completed a deal on Jun 10 ’25 to sell 0.75 million shares. Meanwhile, 10% Owner VIGANO PAUL R sold 0.75 million shares on Jun 10 ’25.